Beitrag schreiben
Ansicht
-
Umgekehrte Sortierung (neuste zuerst)
-
Die letzten 30 Beiträge
-
500 Beiträge pro Seite
[ Seite: 1, 2, 3 … 15, 16, 17, neuster Beitrag ]
schrieb am 17.05.10 21:50:10
Antwort auf Beitrag Nr.:
39.535.235 von Mad Dargel am 17.05.10
21:21:37jetzt kommt wieder diese alte leier mit den
stopp-loss ja oder nein. das hör ich nun schon 100 jahre.
wer ausgestoppt wurde kann zufrieden sein, der verlust war vorher
bekannt. punkt.
bei dem volumen hat man sicher auch keine allzu große slippage
bekommen (was ich gesehen haben). auch gut.
und wer keinen Stopp drinnen hatte (nach meinung einiger
neunmalklugen hier), der hat vlt. einen margin-call bekommen und
einen herzinfarkt. das wäre dumm.
Bernecker1977
schrieb am 18.05.10 07:37:15
Antwort auf Beitrag Nr.:
39.505.967 von ORBP am 12.05.10
11:10:59dazu kann bernie aber wesentlich mehr
sagen.
Klaro, ist aber nicht das Hauptthema hier
Gruß Bernie
schrieb am 18.05.10 09:45:35
Antwort auf Beitrag Nr.:
39.535.414 von xytrader am 17.05.10
21:50:10Och, ich bin kein Daytrader, spekuliere ohne
Kredit und in der Regel ohne Hebel. Ich gebe zu, dass ich zur Zeit
meine EON Dividende in ein paar Optionscheine *ehm* investiert habe
(naja ist eher eine Wette).
Wer einen margin call riskiert, wird eh irgendwann
geschlachtet.
Man kann durch keinen Keller gehen, wird schnell unruhig und so
kann man auch schnell untergehen.
Wenn ich meine, ein Kurs sei günstig, dann kaufe ich. Ich verkaufe
dann nicht, nur weil der Kurs am nächsten Tag noch günstiger wird.
Ich versuche gar nicht erst, über richtiges Timing nachzudenken:
Das klappt bei mir sowieso nicht. Ich verkaufe aber natürlich, wenn
ich zum Entschluss gekommen bin, die falsche Aktie im Depot zu
haben.
Börse ist für mich Überraschung und Veränderung und in erster Linie
Psychologie. Und die Börse ist eine kleine Sau. Irgendwann
verarscht sie jeden (natürlich auch mich). Da ich der Meinung bin,
dass jeder mal an der Börse gut gewinnt, der erfolgreiche Speklant
sich von den Nichterfolgreiche aber in erster Linie durch seine
Verluste unterscheidet, achte ich halt darauf, dass man mich nicht
grillen kann. Und das bedeutet halt, dass ich gerne herausfinde,
bei welchen Sachen man sich sehr schön die Finger verbrennen kann.
Damit ich es lasse.
Meine erste und vorletzte Stopp Loss Party hatte ich 1989. Meine
Letzte als ein paar Spinner in Moskau geputsch hatten.
Am längsten hatte es aber gedauert, bis ich gelernt hatte, ohne
Kredit und Hebel zu spekulieren.
Gelernt ist natürlich relativ: Es bezieht sich nur auf mich und
meine Art , an der Börse den heiligen Gral zu suchen.
Und es bedeutet, dass ich denke, dass es an der Börse nie
langfristig ein erfolgreiches System gibt, weil die Börse immer
wieder die Regeln ändert. Mal funktioniert also Stopp loss und mal
haut es einen weg. Und weil es einen auch mal weghauen kann, taugt
es nichts.... naja zumindest für mich.
schrieb am 21.05.10 00:43:00
Antwort auf Beitrag Nr.:
39.536.964 von Mad Dargel am 18.05.10
09:45:35Tja, dieses mal habe ich wohl einen Fehler
gemacht. Meine EON Dividende habe ich mal zum Zocken genutzt:
Zuerst einen Goldput Schein. Und den habe ich gestern verkauft, um
in einen Call auf die Münchener Rück zu gehen. Es ist zwar nur eine
Dividende, aber ich glaube, es gibt einen Totalverlust.
Was denn das?
Staatsanleihen erleben einen absoluten Boom, weil natürlich alle
Staaten pleite sind und Aktien will keiner haben. Nichts läuft,
ausser man will Gold, weil es ja Inflation geben soll, weswegen man
noch mehr Staatsanleihen kauft oder wie?
6 Prozent Dividende sind mist, nicht mal 3 Prozent bei
Staatsanleihen sind Top.
Und natürlich Gold, aber nicht Öl.
Der Markt ist völlig aus dem Gleichgewicht.
Es kann nur eine Seite stimmen. Aber mit meinen Optionscheinen
spiele ich auch gegen die Zeit. Und das... war ein Fehler. Normaler
Weise gab es lange keine besseren Gründe , um Aktien zu kaufen.
Aber es sollten dann auch Aktien sein.
Der Markt wird zur Zeit aber nicht durch Hirn bestimmt. Weil
nämlich Gold steigt, weil wir Inflation bekommen werden und
deswegen jeder Staatsanleihen kauft.
Wir haben einen Markt ohne Hirn. Und da braucht es Zeit. Tja,
verzockt. Selber schuld.
Aber ich bleibe dabei: Aktien selbst sind günstig.
schrieb am 03.08.10 22:12:55
P&G Reports Fourth Quarter and Fiscal Year-End Results; Q4
Volume Growth Accelerates to +8%, Market Share Growing, EPS In-Line
With Targets
CINCINNATI, Aug. 3, 2010 /PRNewswire via COMTEX/ -- The Procter
& Gamble Company (NYSE: PG) net sales grew five percent to
$18.9 billion for the fourth quarter and three percent to $78.9
billion for fiscal 2010. Organic sales, which exclude the impact of
acquisitions, divestitures and foreign exchange, grew four percent
for the quarter and three percent for the fiscal year. Unit volume
accelerated throughout the fiscal year and was up eight percent in
the fourth quarter driven by growth in all business segments,
regions, and key countries. The company grew global market share
for the quarter, with all regions holding or growing share.
(Logo: http://photos.prnewswire.com/prnh/20090115/CLTH035LOGO-a
)
(Logo: http://www.newscom.com/cgi-bin/prnh/20090115/CLTH035LOGO-a
)
Diluted net earnings per share were $0.71 for the fourth quarter
and $4.11 for the fiscal year, near the top end of the Company's
guidance range of $4.06 to $4.12. Diluted net earnings per share
from continuing operations increased four percent in fiscal 2010 to
$3.53. Core EPS, which represents diluted net earnings per share
from continuing operations excluding certain items, was up six
percent to $3.67 for the fiscal year driven by sales growth and
operating margin expansion. The Company generated record adjusted
free cash flow of $14 billion in fiscal 2010.
"We are executing on all three dimensions of our growth strategy -
touching and improving more consumers' lives, in more parts of the
world, more completely," said Chairman of the Board, President and
Chief Executive Officer Bob McDonald. "Our results in fiscal 2010
were ahead of our original expectations, and we are pleased with
the trend of the business. The investments we've made in
innovation, marketing support and consumer value have delivered
accelerating unit volume and profitable market share growth
throughout the year, which are clear indications that our strategy
is working."
Executive Summary
* Volume growth accelerated throughout the fiscal year behind a
strong innovation program and marketing investments. Fourth quarter
growth of eight percent was the strongest in 22 quarters. All
business segments, regions and key countries contributed to volume
growth for the quarter.
* Net sales increased five percent for the fourth quarter and three
percent for the fiscal year. Organic sales grew four percent for
the quarter and three percent for fiscal 2010.
* Global market share was up for the quarter, with all regions
holding or growing share. Share is growing in businesses
representing approximately 60% of sales, roughly double prior year
levels. Market share growth accelerated throughout the fiscal
year.
* Diluted net earnings per share from continuing operations
declined five percent to $0.71 in the fourth quarter and increased
four percent to $3.53 for the fiscal year.
* Core EPS declined nine percent for the quarter to $0.71 as sales
growth was more than offset by increased marketing spending. Core
EPS increased six percent for the full fiscal year to $3.67 driven
by sales growth and gross margin expansion.
* Operating cash flow was $16.1 billion for the fiscal year, an
increase of eight percent versus the prior year. Adjusted free cash
flow, which is operating cash flow less capital spending and the
after-tax impacts of the global pharmaceuticals divestitures, was a
record $14.0 billion for the year and 125 percent of net earnings
excluding the impacts of the global pharmaceuticals
divestitures.
April - June Quarter Discussion
Volume growth accelerated to eight percent, the fastest pace of
organic growth in 22 quarters. Growth was broad-based, with
mid-single-digit or higher growth in all reportable segments and
regions, led by double-digit growth in developing regions. Net
sales for the fourth fiscal quarter increased five percent to $18.9
billion driven by new product innovation, increased marketing
spending and incremental merchandising support. Global market share
growth was positive with all regions flat or growing share for the
first time in 11 quarters. Key initiatives for the quarter include
the launches of Gillette Fusion ProGlide, Olay Regenerist
Micro-Sculpting Serum and Gucci by Gucci Pour Homme Sport, major
brand restage of Pantene in North America, an upgrade to Bounty and
expansions of Pampers Dry Max to Western Europe and Fairy dish care
into Turkey. Favorable foreign exchange also contributed to net
sales growth, adding one percent. Pricing lowered net sales by one
percent. Mix reduced net sales by three percent due mainly to
negative geographic mix impacts behind disproportionate growth in
developing markets, which have lower than company average selling
prices. Organic sales grew four percent for the quarter.
Operating margin declined 310 basis points for the quarter behind
higher selling, general and administrative expenses (SG&A) as a
percentage of net sales, partially offset by higher gross margin.
SG&A as a percentage of net sales increased 360 basis points
mainly behind increased marketing investments to support key
initiative launches. Gross margin expanded 50 basis points driven
by manufacturing cost savings, partially offset by unfavorable
product mix and higher commodity costs.
Diluted net earnings per share from continuing operations and Core
EPS were $0.71, representing declines of five and nine percent,
respectively. Net earnings from continuing operations were down six
percent to $2.2 billion for the quarter as increased sales and a
lower tax rate were more than offset by lower operating margin. The
tax rate on continuing operations decreased mainly due to favorable
impacts of a foreign audit resolution and other tax items and tax
benefits related to exercising the call option on an outstanding
bond.
Fiscal Year Discussion
Net sales increased three percent to $78.9 billion for fiscal 2010
behind accelerating volume growth of four percent. All geographic
regions contributed to volume growth, led by high-single-digits
growth in the Asia and Central & Eastern Europe/Middle
East/Africa (CEEMEA) regions. Unit volume increased in five of six
reportable segments behind key initiative launches: Head &
Shoulders Scalp Care, restages of Pantene, Pantene Protect &
Care, Olay Regenerist Eye Roller, Olay Men Solutions, Gillette
Fusion ProGlide, Gillette ProSeries, Crest 3D White, Oral-B Pro
Health toothpaste, Always Simply Fits, Tampax Pearl Adaptive
Protection, Tide Stain Release, Ariel with Actilift, Bounce Dryer
Bar, Tide Naturals, Sarasa, Febreze Home Collections, Bounty and
Charmin Upgrades, Pampers Dry Max and Pampers Simply Dry. Price
increases of one percent were offset by negative geographic and
product mix impacts. Unfavorable foreign exchange reduced net sales
by one percent. Organic sales grew three percent.
Operating margin increased 30 basis points for the year due to
gross margin expansion, mostly offset by higher SG&A as a
percentage of net sales. Gross margin expanded 250 basis points to
52.0 percent of net sales behind manufacturing cost savings,
commodity and energy cost reductions and price increases. SG&A
increased 220 basis points to 31.7 percent of net sales mainly due
to increased marketing spending. Advertising spending, which is the
majority of total marketing expense, increased more than $1 billion
versus the prior fiscal year to $8.6 billion, or 10.9 percent of
net sales.
Net earnings from continuing operations increased two percent
driven by sales growth and operating margin expansion, partially
offset by a higher tax rate. The tax rate on continuing operations
increased mainly due to significant tax benefits in the base period
related to adjustments to tax reserves. Diluted net earnings per
share from continuing operations increased four percent to $3.53 in
fiscal 2010 driven by sales growth, operating margin expansion and
share repurchases, partially offset by a higher tax rate. Core EPS
grew six percent for the fiscal year.
Diluted net earnings per share declined four percent to $4.11 for
the fiscal year due to the loss of contribution from discontinued
operations and lower current year gains on the sale of discontinued
operations, partially offset by higher earnings from continuing
operations. Diluted net earnings per share from discontinued
operations were $0.87 in fiscal year 2009 and $0.58 in fiscal year
2010.
Operating cash flow increased eight percent in fiscal 2010 to $16.1
billion. Adjusted free cash flow was $14.0 billion, an all time
record and 125 percent of net earnings excluding the impacts of the
global pharmaceuticals divestitures. Capital expenditures were 3.9
percent of net sales. The Company repurchased $6.0 billion of
P&G stock in fiscal 2010 and increased its quarterly dividend
by 9.5 percent in April.
Fiscal Year Business Segment Discussion
Beauty GBU
* Beauty net sales increased three percent in fiscal 2010 to $19.5
billion on unit volume growth of three percent. Organic sales grew
three percent versus the prior year on four percent organic volume
growth. Volume growth was driven by high single-digit growth in
developing regions, while volume in developed regions was
consistent with the prior year. Price increases of one percent were
offset by unfavorable geographic and category mix. Hair Care volume
grew mid-single digits behind initiative-driven growth of Pantene,
Head & Shoulders and Rejoice. Female Beauty volume was up low
single digits mainly due to higher shipments of female skin care
and personal cleansing products in Asia and CEEMEA. Salon
Professional volume was down double digits mainly due to the exit
of non-strategic businesses and continued market contractions.
Prestige volume declined low single digits due to continued
contraction of the fragrance market. Net earnings increased two
percent to $2.7 billion driven by net sales growth, partially
offset by the impact of divestiture gains in the prior year and a
higher tax rate in the current year. Higher gross margin driven
primarily by price increases and manufacturing cost savings was
offset by higher SG&A as a percentage of net sales mainly
behind increased marketing spending.
* Grooming net sales increased three percent to $7.6 billion for
the fiscal year on a one percent increase in unit volume. Organic
sales were up three percent. Price increases, taken primarily
across blades and razors and in developing regions to offset
currency devaluations, added four percent to net sales. Product mix
had a negative two percent impact on net sales due mainly to
disproportionate growth of low-cost razor systems in developing
regions and of disposable razors, both of which have lower than
segment average selling prices. Volume in developing regions
increased low single digits, while volume in developed regions was
in line with the prior year. Volume in Male Grooming was up low
single digits mainly due to growth of disposable razors in
developing regions and double-digit growth of Gillette Fusion
behind the Fusion ProGlide launch in North America, partially
offset by declining shipments of legacy systems. Volume in
Appliances was down low single digits behind lower shipments of
home and hair care appliances, partially offset by higher shipments
of shavers and epilators. Net earnings increased nine percent to
$1.5 billion for the fiscal year behind sales growth, operating
margin expansion and a lower tax rate. Operating margin increased
behind improved gross margin due mainly to price increases and
manufacturing cost savings, partially offset by higher SG&A as
a percentage of net sales driven primarily by higher marketing
spending.
Health & Well-Being GBU
* Health Care net sales increased two percent for fiscal 2010 to
$11.5 billion on unit volume growth of three percent. Organic sales
grew two percent. Pricing increases added one percent to net sales
growth behind increases taken in developing regions primarily to
offset currency devaluations. Mix reduced net sales by two percent
primarily due to disproportionate growth of developing regions,
which have lower than segment average selling prices. Volume grew
mid-single digits in developing regions and low single digits in
developed regions. Oral Care volume grew mid-single digits behind
initiative activity in Western Europe, Latin America and Asia.
Personal Health Care volume was up low single digits behind higher
shipments of Vicks and diagnostic products, partially offset by a
continued decline of Prilosec OTC in North America due to increased
competitive activity. Feminine Care volume increased low single
digits behind initiative-driven growth of Always and expansion of
Naturella into China. Net earnings were up one percent to $1.9
billion on higher net sales, partially offset by lower operating
margin. Operating margin contracted due to higher SG&A as a
percentage of net sales driven primarily by higher marketing and
selling expenses, partially offset by higher gross margin from
price increases, lower commodity costs and manufacturing cost
savings.
* Snacks and Pet Care net sales increased one percent to $3.1
billion for the fiscal year. Organic sales were in line with the
prior year. Unit volume declined two percent driven by lower
shipments in Snacks. Price increases, taken primarily to offset
high commodity costs, added three percent to net sales growth.
Product mix reduced net sales by one percent due mainly to the
discontinuation of premium snack products and higher shipments of
large size pet products. Favorable foreign exchange added one
percent to net sales. Volume in Snacks was down mid-single digits
due primarily to price increases and the discontinuation of some
premium snack products. Volume in Pet Care was up low single digits
behind product initiatives, increased marketing spending and
incremental merchandising support. Net earnings increased 39
percent to $326 million driven by higher net sales, increased
operating margins and a lower tax rate. Operating margin expanded
due to higher gross margin behind price increases, commodity cost
declines and manufacturing cost savings, partially offset by higher
SG&A as a percentage of net sales primarily due to higher
marketing spending.
Household Care GBU
* Fabric Care and Home Care net sales increased three percent to
$23.8 billion in fiscal 2010 on a six percent increase in unit
volume. Organic sales grew four percent. Pricing, mix and foreign
exchange each reduced net sales by one percent. Fabric Care volume
grew mid-single digits behind new product launches, value
corrections and incremental merchandising activity. Home Care
volume was up high single digits driven mainly by new product
launches, marketing support increases and market size expansion.
Batteries volume increased mid-single digits primarily due to
growth in Greater China, price reductions to improve consumer value
in North America, and higher demand from business customers. Net
earnings increased 10 percent to $3.3 billion due to higher net
sales and increased operating margin. Operating margin expanded due
to higher gross margin driven primarily by lower commodity costs
and manufacturing cost savings, partially offset by an increase in
SG&A as a percentage of net sales due to higher marketing
spending.
* Baby Care and Family Care net sales increased four percent to
$14.7 billion for the fiscal year on seven percent volume growth.
Organic sales were up five percent. Mix reduced net sales by two
percent driven mainly by disproportionate growth of mid-tier
product lines, larger package sizes and developing regions, all of
which have lower than segment average selling prices. Unfavorable
foreign exchange reduced net sales by one percent. Volume grew
double digits in developing regions and mid-single digits in
developed regions. Volume in Baby Care increased high single digits
behind initiative activity, strong marketing programs to support
new product launches and market size expansion. Volume in Family
Care grew high single digits behind initiative activity on Bounty
and Charmin, increased merchandising and market growth. Net
earnings increased 16 percent to $2.0 billion behind net sales
growth and operating margin expansion. Operating margin expansion
was driven by higher gross margin mainly due to lower commodity
costs and manufacturing cost savings, partially offset by higher
SG&A as a percentage of net sales primarily driven mainly by
higher marketing spending.
Fiscal Year 2011 Guidance
Net sales are expected to increase two to four percent in fiscal
2011. Organic sales are estimated to grow four to six percent.
Unfavorable foreign exchange is expected to reduce net sales growth
by approximately three percent. The net impact of acquisitions and
divestitures is estimated to contribute one percent to net sales
growth. Diluted net earnings from continuing operations and Core
EPS are expected to be in the range of $3.91 to $4.01, up 11 to 14
percent on a continuing operations basis and up seven to nine
percent on a core basis.
July - September 2010 Quarter Guidance
For the July - September quarter, net sales growth is estimated to
be one to three percent. Organic sales are expected to grow three
to five percent, reflecting continued, strong volume momentum,
partially offset by mix and pricing. Unfavorable foreign exchange
is expected to reduce net sales growth by approximately three
percent. Acquisition and divestiture activity is expected to
contribute one percent to net sales for the quarter. Diluted net
earnings per share from continuing operating and Core EPS are
expected to be in the range of $0.97 to $1.01, in line to up four
percent versus prior year Core EPS of $0.97, reflecting the
company's plans to continue strong investment levels in innovation
and marketing support.
schrieb am 12.10.11 18:57:04
12.10.2011 Procter & Gamble schüttet 52,50 US-Cents aus -
Dividende seit dem Jahr 1890
Der Konsumgüterkonzern Procter & Gamble (ISIN: US7427181091,
NYSE: PG) wird seinen Aktionären eine unveränderte Dividende von
52,50 US-Cents ausbezahlen. Damit schüttet der Konzern aus
Cincinnati im Gesamtjahr 2,10 US-Dollar aus. Dies entspricht einer
Dividendenrendite von 3,25 Prozent beim aktuellen Börsenkurs von
64,57 US-Dollar. Die nächste Auszahlung erhalten Aktionäre am dem
15. November 2011.
Procter & Gamble steigerte die Ausschüttung seit 55 Jahren
ununterbrochen. Die letzte Anhebung erfolgte im April dieses
Jahres. Im Durchschnitt betrug die jährliche Erhöhung 9,5 Prozent.
Seit 1890 erhalten die Aktionäre nun schon eine Dividende. Dabei
unterbrach der Konzern nach eigenen Angaben in noch keinem Jahr die
Dividendenzahlung. P&G wurde 1837 von zwei Europäern aus
England sowie Irland gegründet. Zu den Produkten zählen Ariel,
Braun, Gillette, Pampers oder auch Wella. Seit Jahresanfang weist
die Aktie ein Plus von 0,37 Prozent auf, während der Dow Jones
knapp im Minus liegt.
schrieb am 12.10.11 19:04:04
Zitat von R-BgO12.10.2011
Procter & Gamble schüttet 52,50 US-Cents aus - Dividende seit
dem Jahr 1890
Der Konsumgüterkonzern Procter & Gamble (ISIN: US7427181091,
NYSE: PG) wird seinen Aktionären eine unveränderte Dividende von
52,50 US-Cents ausbezahlen. Damit schüttet der Konzern aus
Cincinnati im Gesamtjahr 2,10 US-Dollar aus. Dies entspricht einer
Dividendenrendite von 3,25 Prozent beim aktuellen Börsenkurs von
64,57 US-Dollar. Die nächste Auszahlung erhalten Aktionäre am dem
15. November 2011.
Procter & Gamble steigerte die Ausschüttung seit 55 Jahren
ununterbrochen. Die letzte Anhebung erfolgte im April dieses
Jahres. Im Durchschnitt betrug die jährliche Erhöhung 9,5 Prozent.
Seit 1890 erhalten die Aktionäre nun schon eine Dividende. Dabei
unterbrach der Konzern nach eigenen Angaben in noch keinem Jahr die
Dividendenzahlung. P&G wurde 1837 von zwei Europäern aus
England sowie Irland gegründet. Zu den Produkten zählen Ariel,
Braun, Gillette, Pampers oder auch Wella. Seit Jahresanfang weist
die Aktie ein Plus von 0,37 Prozent auf, während der Dow Jones
knapp im Minus liegt.
Schön, ich ich kaufe keine Produkte von pro und gam